Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|April 9, 2008
Novel molecules targeting dyslipidemia and atherosclerosisA Tavridou, V G Manolopoulos
Current Pharmaceutical Design|September 17, 2009
EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitorsA Tavridou, V G Manolopoulos
Biochemical and Biophysical Research Communications|March 31, 1993
Cyclic strain and forskolin differentially induce cAMP production in phenotypically diverse endothelial cellsV G Manolopoulos, P I Lelkes
Biochemical and Biophysical Research Communications|March 6, 1997
Hypotonicity and thrombin activate taurine efflux in BC3H1 and C2C12 myoblasts that is down regulated during differentiationV G Manolopoulos, G Droogmans, B Nilius
Current Medicinal Chemistry|December 25, 2010
Emerging targets for the treatment of dyslipidemiaA Tavridou, G Ragia, V G Manolopoulos
Journal of Cellular Biochemistry|April 1, 1995
Regulation of the adenylyl cyclase signaling system in various types of cultured endothelial cellsV G Manolopoulos, M M Samet, P I Lelkes
Journal of Autonomic Pharmacology|December 1, 1991
Human plasma-derived material with clonidine displacing substance (CDS)-like properties contracts the isolated rat aortaD Synetos, V G Manolopoulos, D Atlas, et al.
British Journal of Pharmacology|October 1, 1989
Angiotensin converting enzyme activity is present in the endothelium-denuded aortaE Pipili, V G Manolopoulos, J D Catravas, et al.
European Journal of Pharmacology|May 25, 1991
Inositol phosphates formed in rat aorta after alpha 1-adrenoceptor stimulation are inhibited by forskolinV G Manolopoulos, E Pipili-Synetos, A Den Hertog, et al.
Pageof 3